We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Latest Articles

Hand points to brain scan MRI showing areas affected by Alzheimer's disease.
Article

How a Healthy Glymphatic System Could Reduce Alzheimer’s Disease Risk

This article explores how the glymphatic system clears brain waste, its role in Alzheimer’s disease and how lifestyle factors like sleep, diet and vascular health can help maintain its function.
3D-rendered brain shaped like Earth with neural network overlay, symbolizing global Alzheimer’s research.
Article

Dementia Research Is “On the Cusp of a Major Breakthrough”

We spoke with Dr. Niranjan Bose, managing director, Health & Life Sciences Strategy, Gates Ventures, about how proteomics-based biomarkers and international partnerships are changing the future of neurodegenerative disease research.
Digital illustration of a brain with fragments symbolizing the focus on Alzheimer's biomarkers, with white text reading "Biomarkers in Focus" overlayed.
Article

What Blood Biomarkers Can – and Can’t – Tell Us About Alzheimer’s

Researchers are investigating blood-based biomarkers like pTau217 for Alzheimer’s detection, offering a less invasive alternative to traditional methods. However, challenges remain due to the interference of proteins from other organs.
A header image depicting an article from the series "biomarkers in focus".
Article

EEG Biomarkers: The Future of Monitoring Neurological Health?

Learn about the potential of EEG biomarkers in the early detection and monitoring of neurological diseases such as Alzheimer's with Dr. Javier Escudero, reader in biomedical signal processing at the University of Edinburgh.
Colorful digital rendering of a brain illuminated with neural activity, symbolizing psychedelics.
Article

Microdosing Psychedelics: Hype, Hope or Science?

Microdosing psychedelics like LSD and psilocybin is gaining popularity, but science remains inconclusive. Small studies report modest benefits in mood, focus and sleep, though placebo effects loom large.
Hand holding a weight loss drug injector above a bathroom scale with feet in socks.
Article

The Promise and Perils of Weight Loss Drugs

This article examines the rise of GLP-1 weight loss drugs, highlighting their effectiveness in obesity and diabetes management while addressing concerns over side effects, mental health risks, high costs and long-term sustainability.
A patient talking to a doctor as part of a clinical trial with the words Biomarkers in Focus displayed overhead.
Article

How Digital Biomarkers Enable Patient-Centric Clinical Trials

Explore how digital biomarkers are transforming clinical trials with real-time data, continuous monitoring and AI-driven patient insights.
White mouse cradled by the gloved hands of a laboratory worker.
Article

Neuroethics and the Future of the Animal Rights Movement

This article explores some of the reasons animal models are used in neuroscience and how this could change in the future.
Several slides of a brain scan, in red on a black background.
Article

Modeling Tauopathy: How New Mouse Models Could Help Map Alzheimer’s Disease

While amyloid-beta has been a central focus in drug development, increasing evidence points to tau pathology as a more accurate predictor of disease progression. This is where the work of Dr. Naoto Watamura could be vital.
A series of fluorescence microscopy images with tagged proteins showing up in purple and green.
Article

SMART Templates Break CRISPR’s PAM Barrier With 10× Editing Reach

Scientists have developed SMART (silently mutate and repair template), a strategy that dramatically expands the editable range of CRISPR targets by redesigning the repair template without changing the enzyme.
Advertisement